{
    "organizations": [],
    "uuid": "ef5f251089eef95c16fc81bbb5fa40fe9b1a6b33",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-star-pharmaceutical-expects-to-rep/brief-star-pharmaceutical-expects-to-report-an-operating-loss-for-q4-idUSFWN1Q40P0",
    "ord_in_thread": 0,
    "title": "BRIEF-Star Pharmaceutical ‍Expects To Report An Operating Loss For Q4​",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 14 (Reuters) - Star Pharmaceutical Ltd:\n* ‍EXPECTED TO RECORD A SIGNIFICANT DROP IN ITS REVENUE AND REPORT AN OPERATING LOSS FOR 4Q2017​\n* EXPECTED RESULT DUE TO IMPAIRMENT LOSS OF RESEARCH AND DEVELOPMENT PROJECT FUNDS DURING 4Q2017 Source text for Eikon: Further company coverage:\n ",
    "published": "2018-02-14T17:41:00.000+02:00",
    "crawled": "2018-02-15T20:17:59.004+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "star",
        "pharmaceutical",
        "ltd",
        "record",
        "significant",
        "drop",
        "revenue",
        "report",
        "operating",
        "loss",
        "expected",
        "result",
        "due",
        "impairment",
        "loss",
        "research",
        "development",
        "project",
        "fund",
        "4q2017",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}